Anjac Health & Beauty has announced the acquisition of Apollo, a Canadian manufacturer of beauty, personal care and OTC products, including suncare products, for CAD 327 million. In the wake of the acquisition of Cosmetix West in 2019, this operation further expands Anjac’s footprint on the North American continent.
France’s Anjac Health & Beauty, an industrial group specialized in the formulation, manufacturing and filling of cosmetics, medical devices, drugs and food supplements, has completed the acquisition of Apollo Healthcare Corp., a Canada-based company specialized in the development and production of personal care, OTC and wellness products, for CAD 327 million (approximately USD 256 million or EUR 227 million).
Based in Ontario, Canada, Apollo Healthcare Corp. is one of the largest private label personal care product manufacturers in North America, developing and manufacturing products for major North American retailers and brands. Apollo’s customer base spans across major North American drug and mass merchandise retailers, users as well as wholesale clubs. The company’s annual turnover surpasses 100 million euros.
Apollo Healthcare Corp. has been co-founded by Charles and Richard Wachsberg, who will remain shareholders and co-CEOs.
Stronger footprint in North America
With this acquisition, Anjac Health & Beauty group continues their external growth strategy and further strengthens their footprint in North America, after the acquisition of Cosmetics West in 2019.
"We are very pleased to expand our expertise and technologies throughout the North American continent with this major acquisition. Great opportunities are opening up for our international customers especially when it comes to industrial robustness and innovation!," explains Aurélien Chaufour, CEO of Anjac Group.
After Cosmetix West and Feltor in 2019, and Roval Cosmétiques in 2020, Anjac signs with Apollo their 8th acquisition within five years. The Anjac Group now gathers 13 companies representing a total of 21 R&D and manufacturing sites and a global turnover which is now twice bigger than three years ago, reaching EUR 600 million, after the new acquisition.
